BeStock  
Stocks › Biotechnology › AVBP

ArriVent BioPharma AVBP

US equityMarket cap rank #3544Biotechnology
$10.52 −$0.74 (-6.57%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $10.52 0.00%
Open$11.00
Prev close$11.26
Day range$10.38 – $11.35
Volume1.05M
Market cap$544.13M
P/E (TTM)–
Dividend yield–

AVBP Stock News

Headlines matching ArriVent BioPharma or the AVBP ticker, most recent first.

  • Truist Financial Initiates ArriVent BioPharma(AVBP.US) With Buy RatingMarket news · 16 Sep 2026 · Direct mention
  • Analysts Offer Insights on Healthcare Companies: Cellectis SA (CLLS) and ArriVent BioPharma, Inc. (AVBP)TipRanks · 15 Sep 2026 · Direct mention
  • ArriVent BioPharma, Inc. (AVBP) Gets a Buy From GuggenheimTipRanks · 15 Sep 2026 · Direct mention
  • Analysts Are Bullish on Top Healthcare Stocks: Revolution Medicines (RVMD), ArriVent BioPharma, Inc. (AVBP) PositiveTipRanks · 15 Sep 2026 · Direct mention
  • Analysts Offer Insights on Healthcare Companies: AgomAb Therapeutics NV ADR (AGMB), Nuvation Bio (NUVB) and ArriVent BioPharma, Inc. (AVBP)TipRanks · 15 Sep 2026 · Direct mention
  • A Quick Look at Today's Ratings for ArriVent BioPharma(AVBP.US), With a Forecast Between $40 to $45Market news · 15 Sep 2026 · Direct mention
  • H.C. Wainwright Maintains ArriVent BioPharma(AVBP.US) With Buy Rating, Raises Target Price to $47 PositiveMarket news · 17 Aug 2026 · Direct mention
  • Citi Maintains ArriVent BioPharma(AVBP.US) With Buy Rating, Cuts Target Price to $40 NegativeMarket news · 15 Aug 2026 · Direct mention
  • Analysts Conflicted on These Healthcare Names: ArriVent BioPharma, Inc. (AVBP), Zimmer Biomet Holdings (ZBH) and Tecan Group AG (OtherTCHBF)TipRanks · 14 Aug 2026 · Direct mention
  • A Quick Look at Today's Ratings for ArriVent BioPharma(AVBP.US), With a Forecast Between $40 to $50Market news · 14 Aug 2026 · Direct mention
  • Analysts Offer Insights on Healthcare Companies: Kyverna Therapeutics, Inc. (KYTX) and ArriVent BioPharma, Inc. (AVBP)TipRanks · 14 Aug 2026 · Direct mention
  • Analysts Offer Insights on Healthcare Companies: ArriVent BioPharma, Inc. (AVBP) and Alterity Therapeutics (ATHE)TipRanks · 13 Aug 2026 · Direct mention
  • A Quick Look at Today's Ratings for ArriVent BioPharma(AVBP.US), With a Forecast Between $42 to $50Market news · 13 Aug 2026 · Direct mention
  • JonesTrading Maintains ArriVent BioPharma(AVBP.US) With Buy Rating, Maintains Target Price $45Market news · 6 Jul 2026 · Direct mention
  • Guggenheim Maintains ArriVent BioPharma(AVBP.US) With Buy Rating, Maintains Target Price $45Market news · 22 Jul 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on AVBP.

Sign in to join the discussion.

Scroll to Top